These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23627715)

  • 1. Health economics of rubella: a systematic review to assess the value of rubella vaccination.
    Babigumira JB; Morgan I; Levin A
    BMC Public Health; 2013 Apr; 13():406. PubMed ID: 23627715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries.
    Terracciano E; Amadori F; Pettinicchio V; Zaratti L; Franco E
    J Prev Med Hyg; 2020 Mar; 61(1):E98-E108. PubMed ID: 32490275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
    Wichmann O; Ultsch B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1260-9. PubMed ID: 23990088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting rubella for elimination.
    Taneja DK; Sharma P
    Indian J Public Health; 2012; 56(4):269-72. PubMed ID: 23354136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital rubella syndrome: a matter of concern.
    Martínez-Quintana E; Castillo-Solórzano C; Torner N; Rodríguez-González F
    Rev Panam Salud Publica; 2015 Mar; 37(3):179-86. PubMed ID: 25988255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic analyses of rubella and rubella vaccines: a global review.
    Hinman AR; Irons B; Lewis M; Kandola K
    Bull World Health Organ; 2002; 80(4):264-70. PubMed ID: 12075361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries.
    Vynnycky E; Papadopoulos T; Angelis K
    Hum Vaccin Immunother; 2019; 15(2):309-316. PubMed ID: 30285537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses.
    Saito MM; Ejima K; Kinoshita R; Nishiura H
    Int J Environ Res Public Health; 2018 Mar; 15(4):. PubMed ID: 29565821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Wu Y; Wood J; Khandaker G; Waddington C; Snelling T
    Vaccine; 2016 Nov; 34(46):5636-5642. PubMed ID: 27670077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the incidence of congenital rubella syndrome in developing countries.
    Cutts FT; Vynnycky E
    Int J Epidemiol; 1999 Dec; 28(6):1176-84. PubMed ID: 10661666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014.
    Grant GB; Reef SE; Dabbagh A; Gacic-Dobo M; Strebel PM
    MMWR Morb Mortal Wkly Rep; 2015 Sep; 64(37):1052-5. PubMed ID: 26401958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
    Best JM; Castillo-Solorzano C; Spika JS; Icenogle J; Glasser JW; Gay NJ; Andrus J; Arvin AM
    J Infect Dis; 2005 Dec; 192(11):1890-7. PubMed ID: 16267759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella and congenital rubella syndrome: global update.
    Robertson SE; Featherstone DA; Gacic-Dobo M; Hersh BS
    Rev Panam Salud Publica; 2003 Nov; 14(5):306-15. PubMed ID: 14870758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing evidence and uncertainty when considering rubella vaccine introduction.
    Lessler J; Metcalf CJ
    PLoS One; 2013; 8(7):e67639. PubMed ID: 23861777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009.
    Reef SE; Strebel P; Dabbagh A; Gacic-Dobo M; Cochi S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S24-7. PubMed ID: 21666168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella and congenital rubella syndrome control and elimination - global progress, 2000-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(48):983-6. PubMed ID: 24304830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination.
    Metcalf CJ; Lessler J; Klepac P; Cutts F; Grenfell BT
    Epidemiol Infect; 2012 Dec; 140(12):2290-301. PubMed ID: 22335852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant.
    Mangtani P; Evans SJW; Lange B; Oberle D; Smith J; Drechsel-Baeuerle U; Keller-Stanislawski B
    Vaccine; 2020 Jan; 38(5):963-978. PubMed ID: 31839467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008.
    Castillo-Solórzano C; Reef SE; Morice A; Vascones N; Chevez AE; Castalia-Soares R; Torres C; Vizzotti C; Ruiz Matus C
    J Infect Dis; 2011 Sep; 204 Suppl 2():S713-7. PubMed ID: 21954271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005.
    Muller CP; Kremer JR; Best JM; Dourado I; Triki H; Reef S;
    Vaccine; 2007 Jan; 25(1):1-9. PubMed ID: 17262908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.